Priyanka Goyal¹*, Priyanka Ahuja², Anshu Mali³ and Sunil Kumar Singh⁴

¹Department of Anaesthesia, Consultant, Rajiv Gandhi Cancer Institute and Research Centre Rohini, Delhi 110085, India
²Department of Anaesthesia, Senior Resident, ESIC Medical College and Hospital, Faridabad, Haryana-121012, India
³Department of Anaesthesia, Professor, North DMC Medical College and Hindu Rao Hospital, Delhi, India
⁴Department of Community Medicine, Assistant Professor, Shri Atal Bihari Vajpayee Medical College Chhainsa, Faridabad, Haryana-121012, India

*Corresponding Author: Priyanka Goyal, Department of Anaesthesia, Consultant, Rajiv Gandhi Cancer Institute and Research Centre Rohini, Delhi 110085, India.

Received: July 18, 2025; Published: August 06, 2025

Abstract

Introduction: The delta variant of the SARS-CoV-2 virus, which led to the second wave of Coronavirus Disease-19 (COVID-19), had higher infectivity, affecting the lungs, heart, and kidneys more than the alpha variant. The post-COVID syndrome might have profound implications for anaesthetic and perioperative care. As Indian patients presented for cancer surgery after recovering from COVID-19, we felt it was imperative to know about the anaesthetic outcome. But there was a lack of data on the anaesthetic outcome of cancer patients undergoing oncosurgery after recovery from COVID-19 (Delta Variant).

Purpose of study: To evaluate the anaesthetic outcome in cancer patients who underwent oncosurgery after recovering from COVID-19(Delta variant) infection.

Methodology: A retrospective review of 1,500 electronic medical records of patients who underwent oncosurgery between May and October 2021 at a tertiary cancer centre was conducted to include adult patients over 18 years old with RT-PCR-confirmed SARS-CoV-2 infection during India's second wave. Postoperative outcomes within 24–72 hours and at Surgical Intensive Care Unit (SICU) discharge were analyzed.

Results: Out of the 110 patients, 4 (3.6%) experienced adverse anaesthetic outcomes potentially related to prior COVID-19, with no reported mortality. The majority of patients (68.2%) underwent surgery more than eight weeks post-COVID-19, showing favourable recovery profiles.

Conclusion: Elective oncosurgery performed after an 8-week interval post-COVID-19 infection appeared safe from an anaesthetic perspective. These findings may inform perioperative planning for post-COVID cancer patients

Keywords: COVID-19; Anaesthetic Outcome; Oncosurgery; Delta Variant; Second Wave

References

1. Shayan S., et al. “Analysis of the delta variant B.1.617.2 COVID-19”. Clinical Practice 11 (2021): 778-784.
2. Johns Hopkins Coronavirus Resource Centre.
3. GLOBOCAN (2020).
4. L Zhang., et al. “Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China”. Annals of Oncology7 (2020): 894-901.
5. Huang C., et al. “6-month consequences of COVID-19 in patients discharged from hospital: a cohort study”. The Lancet 397 (2021): 220-231.
6. Battistella L., et al. “Long-term functioning status of COVID-19 survivors: a prospective observational evaluation of a cohort of patients surviving hospitalization”. BMJ Open 12 (2022): e057246.
7. American Society of Anesthesiologists. “American Society of Anesthesiologists and Anaesthesia Patient Safety Foundation Joint Statement on Elective Surgery and Anaesthesia for Patients after COVID-19 Infection”. (2020).
8. COVIDSurg Collaborative. Delaying surgery for patients with a previous SARS-CoV-2 infection”. British Journal of Surgery12 (2020): e601-e602.
9. Gundavda M., et al. “Cancer or COVID-19?A review of guidelines for safe cancer care in the wake of the pandemic”. SN Comprehensive Clinical Medicine 2 (2020): 2691-2701.
10. COVIDSurg Collaborative. “Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study”. Lancet (London, England)10243 (2020): 27-38.
11. Lewis., et al. “COVID-19 and the effects on pulmonary function following infection: A retrospective Analysis”. EClinicalMedicine 39 (2021): 101079.
12. Baiocchi., et al. “Early postoperative outcomes among patients with delayed surgeries after preoperative positive test for SARS‐CoV‐2: A case‐control study from a single institution”. Journal of Surgical Oncology 123 (2021): 823-833.
13. Petrovic V., et al. “Pathophysiology of cardiovascular complications in COVID-19”. Frontiers in Physiology 11 (2020): 1-11.
14. John Z Deng., et al. “The Risk of Postoperative Complications After Major Elective Surgery in Active or Resolved COVID-19 in the United States”. Annals of Surgery 275 (2022): 242-246.
15. Anjana S Wajekar., et al. “Pre-Anaesthesia Re-Evaluation in Post COVID-19 Patients Posted for Elective Surgeries: an Online, Cross-Sectional Survey”. Indian Association of Surgical Oncology (2021).

Citation

Citation: Priyanka Goyal., et al. "To Analyze the Anaesthetic Outcome in Post-COVID-19 Patients (Second Wave - Indian Scenario) Who Underwent Oncosurgery at a Single Tertiary Oncology Care Centre - A Retrospective Study". Acta Scientific Clinical Case Reports 6.9 (2025): 03-10.

Copyright

Copyright: © 2025 Priyanka Goyal., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.